NICE recommends GLP-1 receptor agonists for type 2 diabetes when metformin and other oral medications fail to achieve adequate glycaemic control, particularly with BMI 35 kg/m or weight-related comorbidities
These gastrointestinal issues are generally mild to moderate and tend to decrease over time as the body adjusts to the medication
Comprehensive Progress Tracking: The program offers tools to monitor your progress towards your goals, including dietary intake, exercise, weight changes, and other health metrics, helping you stay informed about your journey
Ozempic works by mimicking the hormone in the body known as GLP-1
Our guides on how to inject GLP-1 medications and tirzepatide injection technique cover proper administration
However, the anti-inflammatory benefits observed in clinical trials are well-documented